{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:41:13Z","timestamp":1784302873679,"version":"3.55.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>SSc is a complex disease that affects various target organs, making it difficult to assess response and determine remission or relapse. A baseline neutrophil-to-lymphocyte ratio (NLR) &amp;gt;2.95 is associated with severe progressive skin and lung disease and decreased 5-year survival in SSc. However, it is unknown whether NLR changes in response to treatment. To retrospectively evaluate NLR changes as a biomarker for treatment response in SSc.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Progressive diffuse SSc patients who were treated with autologous haematopoietic stem cell transplantation (AHSCT group), with combination therapy of rituximab and MMF (combination group) or chimeric antigen receptor-T-cell (CAR-T) therapy group, were recruited along with healthy controls (HC group). NLR, modified Rodnan Skin Score (mRSS) and forced vital capacity (FVC)% predicted were repeatedly assessed over 2\u2009years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifteen patients were recruited in the AHSCT group, 15 in the combination group and 6 patients in the CAR-T group. Baseline mean NLR was high (&amp;gt;2.95) in AHSCT, combination groups and CAR-T compared with HC. All treatment arms showed a statistically significant decrease in mRSS values and an increase in FVC% at each time point up to 12\u2009months. In a linear mixed model, NLR significantly decreased up to 24\u2009months only in the AHSCT group. NLR correlated with mRSS and FVC exclusively in the AHSCT group. NLR increased above 3 in two patients who experienced a relapse after AHSCT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>NLR is a simple biomarker that correlated with outcome measures in SSc following AHSCT but not with conventional therapy or CAR-T therapy. It is suggested that a decrease in NLR following AHSCT may indicate remission, whereas an increase may be associated with exacerbation. Further research is needed to validate these novel findings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae606","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T15:57:16Z","timestamp":1730476636000},"page":"3160-3165","source":"Crossref","is-referenced-by-count":7,"title":["Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-4661","authenticated-orcid":false,"given":"Shiri","family":"Keret","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0315-8017","authenticated-orcid":false,"given":"Lisa","family":"Kaly","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Schett","sequence":"additional","affiliation":[{"name":"Department of Medicine Rheumatology and Immunology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Uniklinikum Erlangen , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum f\u00fcr Immuntherapie (DZI), Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Uniklinikum , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bergmann","sequence":"additional","affiliation":[{"name":"Department of Medicine Rheumatology and Immunology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Uniklinikum Erlangen , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum f\u00fcr Immuntherapie (DZI), Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Uniklinikum , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Feldman","sequence":"additional","affiliation":[{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsila","family":"Zuckerman","sequence":"additional","affiliation":[{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]},{"name":"Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Yehudai-Ofir","sequence":"additional","affiliation":[{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]},{"name":"Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniela","family":"Shouval","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Awisat","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhak","family":"Rosner","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rozenbaum","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Boulman","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Sawaed","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Hardak","sequence":"additional","affiliation":[{"name":"Pulmonology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-6861","authenticated-orcid":false,"given":"J\u00f6rg","family":"Henes","sequence":"additional","affiliation":[{"name":"Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II, University Medical Centre T\u00fcbingen , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleb","family":"Slobodin","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9137-2322","authenticated-orcid":false,"given":"Doron","family":"Rimar","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Faculty of Medicine, Bnai Zion Medical Center, Technion Israel Institute of Technology , Haifa,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"2025050316140336500_keae606-B1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025050316140336500_keae606-B2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","article-title":"Mortality in systemic sclerosis: an international meta-analysis of individual patient data","volume":"118","author":"Ioannidis","year":"2005","journal-title":"Am J Med"},{"key":"2025050316140336500_keae606-B3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2018.01.020","article-title":"Autologous hematopoietic stem cell transplantation for systemic sclerosis: a systematic review and meta-analysis","volume":"24","author":"Shouval","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025050316140336500_keae606-B4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"2025050316140336500_keae606-B5","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"Van Laar","year":"2014","journal-title":"JAMA"},{"key":"2025050316140336500_keae606-B6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"SCOT Study Investigators. Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"2025050316140336500_keae606-B7","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/rheumatology\/kead457","article-title":"Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy","volume":"63","author":"Keret","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316140336500_keae606-B8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/ard-2023-223952","article-title":"Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells","volume":"82","author":"Bergmann","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025050316140336500_keae606-B9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/acr.24880","article-title":"Blood neutrophil count and neutrophil-to-lymphocyte ratio for prediction of disease progression and mortality in two independent systemic sclerosis cohorts","volume":"75","author":"Wareing","year":"202","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025050316140336500_keae606-B10","doi-asserted-by":"crossref","first-page":"e20576","DOI":"10.1016\/j.heliyon.2023.e20576","article-title":"Association between neutrophil\/lymphocyte ratio and disease severity in scleroderma patients","volume":"9","author":"Nejatifar","year":"2023","journal-title":"Heliyon"},{"key":"2025050316140336500_keae606-B11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4078\/jrd.2017.24.3.138","article-title":"Neutrophil-to-lymphocyte ratio in diagnosis of systemic sclerosis for prediction of interstitial lung disease","volume":"24","author":"Jung","year":"2017","journal-title":"J Rheum Dis"},{"key":"2025050316140336500_keae606-B12","doi-asserted-by":"crossref","first-page":"785275","DOI":"10.3389\/fimmu.2021.785275","article-title":"N-formyl methionine peptide-mediated neutrophil activation in systemic sclerosis","volume":"12","author":"Kuley","year":"2021","journal-title":"Front Immunol"},{"key":"2025050316140336500_keae606-B13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/annrheumdis-2021-221313","article-title":"Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease","volume":"81","author":"Assassi","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025050316140336500_keae606-B14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/annrheumdis-2019-215770","article-title":"Myeloablation followed by autologous stem cell transplantation normalizes systemic sclerosis molecular signatures","volume":"78","author":"Assassi","year":"2019","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae606\/60741779\/keae606.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/3160\/60741779\/keae606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/3160\/60741779\/keae606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:14:19Z","timestamp":1746303259000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/5\/3160\/7863300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,11,1]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae606","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,11,1]]}}}